- Telehealth Visits
- Insurance plan information
Devanshi Dove, MD
Endocrinology- Telehealth Visits
- Insurance plan information
Devanshi Dove, MD
Endocrinology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Devanshi Dove is an endocrinologist who cares for patients with all types of endocrine conditions (diseases of the body’s hormone production system). Her interests include thyroid disorders, adrenal disorders, pituitary disease, osteoporosis and diabetes – particularly the management of hospitalized patients with diabetes as well as fracture prevention.
Dove has conducted extensive research on osteoporosis and low bone mineral density, as well as on type 1 diabetes and retinopathy (damage to blood vessels in the retina, the eye's light-sensitive structure). She also pioneered a project to improve education about and use of insulin pumps in the hospital.
Dove earned her medical degree at the Geisel School of Medicine at Dartmouth. She completed a residency in internal medicine at Massachusetts General Hospital, an affiliate of Harvard Medical School followed by a fellowship in endocrinology at UCSF.
Education & training
Board certification
- Endocrinology Diabetes & Metab, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Endocrinology, Diabet & Metabo, UCSF Graduate Medical Education
Residency
- Internal Medicine, Massachusetts General Hospital GME
Degree
- MD, Dartmouth Medical School
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%224730%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224730%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.